DBV Technologies S.A. Operating Expenses 2011-2026 | DBVT

Annual Operating Expenses DBV Technologies S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
121 M	92.2 M	101 M	104 M	135 M	152 M	166 M	145 M	116 M	45.6 M	39 M	20 M	13.6 M	7.32 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
166 M	7.32 M	89.9 M

Quarterly Operating Expenses DBV Technologies S.A.

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
42.6 M	27.4 M	31.4 M	35 M	30 M	20.6 M	27.4 M	23.4 M	-	20.1 M	25.4 M	19.3 M	-	25.7 M	29.6 M	32.6 M	-	33.9 M	51.3 M	45.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
51.3 M	19.3 M	30.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
AstraZeneca PLC AZN	17.6 B	$ 93.52	-1.2 %	$ 96.9 B	Britain
Autolus Therapeutics plc AUTL	145 M	$ 1.52	-16.3 %	$ 388 M	Britain
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.59	1.99 %	$ 8.64 B	Australia
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Biogen BIIB	5.39 B	$ 184.48	-1.67 %	$ 26.9 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
BioNTech SE BNTX	512 M	$ 102.17	2.32 %	$ 27.2 B	Germany
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Can-Fite BioPharma Ltd. CANF	14 M	$ 4.25	1.67 %	$ 9.25 B	Israel
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Ascendis Pharma A/S ASND	338 M	$ 207.49	2.22 %	$ 5 B	Danmark
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Catalyst Biosciences CBIO	176 M	$ 10.84	0.46 %	$ 714 M	USA
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
Corcept Therapeutics Incorporated CORT	189 M	$ 37.35	-0.4 %	$ 3.86 B	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Catalyst Pharmaceuticals CPRX	190 M	$ 23.18	2.02 %	$ 2.75 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Celldex Therapeutics CLDX	58.1 M	$ 25.59	-6.54 %	$ 1.65 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Cellectis S.A. CLLS	109 M	$ 4.22	-4.2 %	$ 116 M	France
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	168 M	$ 29.43	6.09 %	$ 1.43 B	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	106 M	$ 9.66	2.28 %	$ 1.53 B	Britain
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Arrowhead Pharmaceuticals ARWR	731 M	$ 66.05	2.3 %	$ 8.83 B	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Crinetics Pharmaceuticals CRNX	340 M	$ 55.11	3.49 %	$ 4.45 B	USA
Abeona Therapeutics ABEO	50.6 M	$ 5.14	-1.06 %	$ 110 M	USA
CRISPR Therapeutics AG CRSP	504 M	$ 55.17	2.47 %	$ 4.65 B	Schweiz
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Axon Enterprise AXON	1.18 B	$ 632.29	0.09 %	$ 47.9 B	USA
ADiTx Therapeutics ADTX	27.4 M	$ 0.81	1.96 %	$ 10.7 K	USA
Aytu BioScience AYTU	53.7 M	$ 2.7	2.27 %	$ 17 M	USA